Steven Cohen’s AstraZeneca AZN Stock Holding History

Steven Cohen’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.25M	Buy	11,850 +800	+7%	+$150K	﹤0.01%	2318
2026 Q1	$2.18M	Buy	11,050 +4,100	+59%	+$791K	﹤0.01%	2252
2025 Q4	$1.28M	Buy	6,950 +200	+3%	+$35.1K	﹤0.01%	2745
2025 Q3	$1.04M	Hold	6,750	–	–	﹤0.01%	1685
2025 Q2	$943K	Sell	6,750 -143,250	-96%	-$20.1M	﹤0.01%	1580
2025 Q1	$22.1M	Buy	+150,000	New	+$21.7M	0.05%	425
2024 Q1	–	Sell	-5,250	Closed	-$707K	–	2176
2023 Q4	$707K	Hold	5,250	–	–	﹤0.01%	1501
2023 Q3	$711K	Hold	5,250	–	–	﹤0.01%	1430
2023 Q2	$751K	Hold	5,250	–	–	﹤0.01%	1179
2023 Q1	$729K	Sell	5,250 -362,800	-99%	-$48.8M	﹤0.01%	1161
2022 Q4	$49.9M	Buy	368,050 +358,600	+3,795%	+$45M	0.17%	155
2022 Q3	$1.04M	Hold	9,450	–	–	﹤0.01%	1049
2022 Q2	$1.25M	Buy	+9,450	New	+$1.24M	0.01%	1026
2019 Q3	–	Sell	-714,050	Closed	-$59M	–	1135
2019 Q2	$59M	Buy	+714,050	New	+$56M	0.31%	75
2017 Q2	–	Sell	-600,000	Closed	-$37.4M	–	830
2017 Q1	$37.4M	Buy	+600,000	New	+$34.9M	0.21%	133
2015 Q3	–	Sell	-50,200	Closed	-$3.2M	–	759
2015 Q2	$3.2M	Buy	+50,200	New	+$3.44M	0.02%	517
2014 Q4	–	Sell	-400,000	Closed	-$28.6M	–	664
2014 Q3	$28.6M	Buy	400,000 +175,000	+78%	+$12.8M	0.22%	131
2014 Q2	$16.7M	Buy	+225,000	New	+$16.3M	0.11%	233

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Steven Cohen's AZN Position: Q2 2026 in Review

Steven Cohen reduced its AstraZeneca (AZN) stake by 42% in Q2 2026, selling an estimated $98.3M and leaving 711,547 shares worth $135M. The position accounts for 0.15% of the portfolio, ranked #143.

Steven Cohen first reported a position in AZN in Q2 2014 and has held it in 37 quarters since. The position peaked at $264M in Q3 2022. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Steven Cohen held 711,547 shares of AstraZeneca worth $135M as of Q2 2026.
Steven Cohen sold 522,418 AstraZeneca shares in Q2 2026, an estimated $98.3M.
AstraZeneca made up 0.15% of Steven Cohen's portfolio in Q2 2026, its #143 holding.
Steven Cohen first reported a position in AstraZeneca in Q2 2014 and has held it in 37 quarters since.
Steven Cohen's AstraZeneca position peaked at $264M in Q3 2022.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.